PLX - Protalix BioTherapeutics, Inc.

QQQ $ 617.29 $ -4.55 (-0.73 %)

DIA $ 470.58 $ -1.47 (-0.31 %)

SPY $ 674.24 $ -2.25 (-0.33 %)

TLT $ 89.71 $ 0.15 (0.16 %)

GLD $ 366.69 $ -0.57 (-0.16 %)

Previous Close

$ 2.38

Open

$ 2.36

Bid

$ 2.29 x 5

Ask

$ 2.30 x 300

Day's Range

$ 2.30 - $ 2.32

52 Week Range

$ 1.16 - $ 3.10

Volume

522,619

Average Volume

Market Cap

189.76M

Beta (5Y Monthly)

$ 0.78

PE Ratio (TTM)

$ 30.24

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-09-2025	03-31-2025	10-Q
3	03-17-2025	12-31-2024	10-K
4	11-14-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-10-2024	03-31-2024	10-Q
7	03-14-2024	12-31-2023	10-K
8	11-06-2023	09-30-2023	10-Q
9	08-07-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	02-27-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-15-2022	06-30-2022	10-Q
14	05-16-2022	03-31-2022	10-Q
15	03-31-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	05-14-2021	03-31-2021	10-Q
19	03-30-2021	12-31-2020	10-K
20	10-29-2020	09-30-2020	10-Q
21	08-10-2020	06-30-2020	10-Q
22	06-01-2020	03-31-2020	10-Q
23	03-12-2020	12-31-2019	10-K
24	11-07-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-06-2019	03-31-2019	10-Q
27	03-18-2019	12-31-2018	10-K
28	11-07-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-09-2018	03-31-2018	10-Q
31	03-06-2018	12-31-2017	10-K
32	11-08-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	03-16-2017	12-31-2016	10-K
36	11-09-2016	09-30-2016	10-Q
37	08-08-2016	06-30-2016	10-Q
38	05-09-2016	03-31-2016	10-Q
39	03-08-2016	12-31-2015	10-K
40	11-09-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Protalix BioTherapeutics Unit Requests Ree...
11/03/2025 21:33:09

Chiesi Global Rare Diseases, a business unit of the Chiesi Group, and Protalix BioTherapeutics, Inc. (NYSE American: PLX), have...

why-is-protalix-biotherapeutics-stock-falling-on-friday

Why Is Protalix BioTherapeutics Stock Fall...
10/17/2025 15:23:15

EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data ...

12 Health Care Stocks Moving In Friday's P...
10/17/2025 12:13:10

Protalix BioTherapeutics Says CHMP Denies ...
10/17/2025 11:03:02

12 Health Care Stocks Moving In Thursday's...
10/02/2025 21:06:15

Protalix BioTherapeutics Q2 Sales $15.658M...
08/14/2025 10:51:53

Protalix BioTherapeutics (AMEX:PLX) reported quarterly sales of $15.658 million which beat the analyst consensus estimate of $1...

Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

Preview: Protalix BioTherapeutics's Earnings
08/13/2025 17:02:31

Protalix BioTherapeutics Appoints Gilad Ma...
07/21/2025 10:51:50

Protalix BioTherapeutics Added To Russell ...
06/30/2025 10:52:45

12 Health Care Stocks Moving In Friday's P...
05/09/2025 12:10:06

Protalix BioTherapeutics Q1 EPS $(0.05) Mi...
05/09/2025 10:53:23

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate ...

Earnings Scheduled For May 9, 2025
05/09/2025 08:32:15

Uncovering Potential: Protalix BioTherapeu...
05/08/2025 18:02:54

protalix-biotherapeutics-says-with-debt-fully-repaid-its-well-positioned-to-execute-strategy-through-2025-and-beyond

Protalix BioTherapeutics Says With Debt Fu...
03/17/2025 15:56:28

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start ...

Protalix BioTherapeutics FY 2024 GAAP EPS ...
03/17/2025 11:00:39

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of...

Earnings Scheduled For March 17, 2025
03/17/2025 08:32:11

HC Wainwright & Co. Maintains Buy on Prota...
02/03/2025 11:51:18

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Protalix BioTherapeutics (AMEX:PLX) with a Buy and raises the p...

Chiesi Global Rare Diseases, A Business Un...
12/09/2024 11:47:24

Chiesi Global Rare Diseases, a business unit of the Chiesi and Protalix BioTherapeutics announced that the European Medicines A...

Protalix BioTherapeutics Q3 2024 GAAP EPS ...
11/14/2024 11:54:44

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate ...